Product Information
ADMELOG 100 UNIT/ML VIAL is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $9.3938 per ML under NDC 00024592410. Its NADAC has been published 433 times since Jun 20, 2018.
Strength
100 U/mL
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00024592410
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Effective Date
9/23/2026
Active Ingredients
INSULIN LISPROApproval Type
Biologic (BLA)
FDA Application
BLA209196On Market Since
12/11/2017
Pharmacological Classes
Price Statistics
The NADAC for ADMELOG 100 UNIT/ML VIAL has been published 433 times since Jun 20, 2018, and over the history we have for it it has declined 58.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.3938 per ML |
|---|---|
| All-time high | $22.5572 (Apr 10, 2019) |
| All-time low | $9.3923 (Mar 22, 2023) |
| 52-week high | $9.4029 |
| 52-week low | $9.3926 |
| Median price | $9.4277 |
| Average price | $12.0314 |
| Largest weekly change | -44.0% (Jul 10, 2019) |
| Weeks tracked | 433 |
| Tracking since | Jun 20, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sanofi-Aventis U.S. LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
insulin lispro market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Insulin Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ADMELOG 100 UNIT/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for ADMELOG 100 UNIT/ML VIAL, manufactured by Sanofi-Aventis U.S. LLC, is $9.3938 per ML (NDC 00024592410), effective Sep 30, 2026.
How has the price of ADMELOG 100 UNIT/ML VIAL changed over time?
Over the history we have for it, the NADAC for ADMELOG 100 UNIT/ML VIAL has declined 58.4%. It has been tracked across 433 weekly CMS publications since Jun 20, 2018.
What are the highest and lowest recorded NADAC prices for ADMELOG 100 UNIT/ML VIAL?
Since Jun 20, 2018, the NADAC for ADMELOG 100 UNIT/ML VIAL has ranged from a low of $9.3923 (Mar 22, 2023) to a high of $22.5572 (Apr 10, 2019), with a median of $9.4277 per ML.
Are there cheaper alternatives to ADMELOG 100 UNIT/ML VIAL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ADMELOG 100 UNIT/ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures ADMELOG 100 UNIT/ML VIAL?
ADMELOG 100 UNIT/ML VIAL (NDC 00024592410) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.